ISPOR eBulletin March 2007


The ISPOR eBULLETIN provides updates of recent ISPOR activities and events. For detailed information on ISPOR activities, members are encouraged to go to: Please share these new ISPOR activities with your colleagues.


Value in Health Volume 10, Issue 3 On-Line Early

Value in Health Volume 10, Issue 3 is now available On-Line Early.  

Value in Health >>    


ISPOR CONNECTIONS Volume 13, Issue 1 Now On-Line

ISPOR CONNECTIONS Volume 13, Issue 1 is now available on-line.  Featured articles include: POLICY ANALYSIS: "Reimbursement of Drugs in Germany: A Road Map for the Approval Process," OUTCOMES ASSESSMENT: "A Collaborative Approach to Patient-Reported Outcome (PRO) Instrument Development: The EXACT-PRO Initiative," and ECONOMIC EVALUATION: "The Missing Link: Managing Missing Data in Economic Evaluations".



ISPOR Launches THREE NEW Patient Reported Outcomes
Good Research Practices Task Forces

Recently, the FDA issued a draft Guidance for the Industry on Patient-Reported Outcome (PRO) Measures and the EMEA issued a Reflection Paper on the Regulatory Guidance for the Use of Health Related Quality of Life Measures in the Evaluation of Medicinal Products. In comments to the FDA, ISPOR members identified a need for clarity on PRO measurements. The ISPOR Health & Science Policy Council recommended PRO Task Forces on Good Research Practices to address these key issues , which was recently approved by the Board of Directors leading to the development of the following 3 task forces:

PRO: Use of Existing Instruments & Their Modification
Objective: Development of good research practices for assessing existing instruments for use in label claim studies, identifying the concepts contained in existing instruments, obtaining patient input if not used in original instrument, development of instruments used in a battery and modification of these instruments including use in new measurement concept, use in new population, change in item content, change in mode of administration, and assessment of measurement properties for revised instruments.


PRO: Changing Culture or Language of Application

Chair: Diane Wild MSc, Director, Oxford Outcomes

Objective: Development of good research practices for adapting or translating an instrument from one language/culture to another including translation measurement properties and acceptability of pooling data in multi-language trials.


PRO: Changing Mode of Administration/ePRO

Chair: Stephen J. Coons PhD, Professor of Pharmacy and Public Health, University of Arizona

Objective: Development of good research practices for changing the mode of administration (e.g. paper to computer, supervised to self questionnaire) and use of electronic PRO instruments.


If you are interested in joining a PRO task force, please e-mail:

ISPOR Task Forces>>


ISPOR Launches NEW Health Care Decisions Using Outcomes Research SIG

The SIG’s goal is to increase understanding of how health care decisions are made and to increase the use of clinical, economic, and patient reported outcomes research in health care decision-making.
Employer/Insurer Perspective Working Group>>
Hospital Administrator Perspective Working Group>>
Disease/Health Management Working Group>>
Risk Benefit Management Working Group>>

For more information and to join:
Health Care Decisions Using Outcomes Research SIG (HCDUOR)>>

Journal of Managed Care Pharmacy

In association with The Academy of Managed Care Pharmacy (AMCP), ISPOR is happy to provide access to the Journal of Managed Care Pharmacy (JMCP) to its members.

JMCP Volume 31, Issue 1 2007 Table of Contents>>

JMCP Volume 31, Issue 2 2007 Table of Contents>>


To view the Pharmacoeconomic Guidelines Around the World - currently representing 23 countries and 28 guidelines, including 21 PE guidelines, 6 submission guidelines for formulary listing, and 1 for journal publication - go to: and click the Pharmacoeconomic Guidelines Around the World link under the Tools for Health Care Decision Makers box on the right-hand side.


This newsletter is provided as a benefit of membership in ISPOR. If you received this from a colleague and are not a current ISPOR member, please consider becoming an individual member or organizational affiliate.  Contact membership services  for more information and its use in health care decisions.


The International Society for Pharmacoeconomics and Outcomes Research is an international organization promoting the science of pharmacoeconomics and health outcomes research.

3100 Princeton Pike, Suite 3E, Lawrenceville, NJ, 08648 USA

Tel: 609-219-0773 Toll Free: 1-800-992-0643 Fax: 609-219-0774







15 March 2007

Nominations Deadline:

ISPOR International Fellowship Award for 2007



27-28 March 2007

ISPOR Brazil Local Chapter Congress



2 April 2007

Abstract Submission Deadline - 1st Latin America Conference





12th Annual International Meeting

1st Brazil Local Chapter Congress


1st Latin America Conference


10th Annual European Congress


ISPOR Book of Terms


Special Interest Groups (SIGs)


Student Network


Local Chapters





eBulletin Index